Related Experiment Videos
Pacing for patients with congestive heart failure and dilated cardiomyopathy
1Department of Medicine, University of Maryland School of Medicine, Baltimore, USA.
Insights
Permanent pacing, particularly biventricular pacing, offers symptomatic relief for heart failure patients. While survival benefits require further study, advanced devices combine pacing with defibrillation for comprehensive care.
Area of Science:
- Cardiology
- Medical Devices
- Heart Failure Management
Background:
- Heart failure with systolic dysfunction has high mortality and frequent arrhythmic deaths.
- Permanent pacing shows symptomatic benefit in select patients with congestive heart failure (CHF).
- Left ventricular and biventricular pacing demonstrate promising results for CHF symptom management.
Purpose of the Study:
- To review the evidence for permanent pacing in congestive heart failure (CHF).
- To discuss the role of implantable cardioverter-defibrillators (ICDs) with biventricular pacing capabilities.
- To evaluate the combined therapeutic potential of pacing and defibrillation in CHF patients.
Main Methods:
- Review of accumulated evidence on permanent pacing in CHF.
- Analysis of recent clinical trial data, including studies on biventricular pacing.
- Discussion of the evolving role of implantable devices in heart failure management.
Main Results:
- Permanent pacing provides symptomatic improvement for some CHF patients.
- Biventricular pacing shows particularly promising results for symptom optimization.
- Data on improved survival from pacing alone is less conclusive.
- Arrhythmic deaths remain a significant concern in CHF with systolic dysfunction.
Conclusions:
- Biventricular pacing is a key therapeutic strategy for optimizing functional status in CHF.
- Implantable cardioverter-defibrillators (ICDs) with biventricular pacing offer combined benefits.
- These advanced devices may play a crucial role in managing CHF patients, improving quality of life and protecting against sudden cardiac death.
Abstract:
Considerable evidence has now accumulated that permanent pacing may provide symptomatic benefit for at least some patients with CHF. Recently, the most promising results with left ventricular or biventricular pacing have been obtained. The data for improvement in survival with pacing is less compelling. The mortality of CHF associated with systolic dysfunction of the left ventricle remains high and arrhythmic deaths are frequent. Clinical trials such as the Sudden Cardiac Death Heart Failure Trial (SCD-HeFT) are currently underway to investigate the role of the implantable defibrillator in patients with heart failure. The development and general availability of ICDs with biventricular pacing capability may play an increasingly important role in the overall therapeutic plan for this group of patients to allow for optimization of functional status with pacing and protection from sudden cardiac death with defibrillation.